{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:01:17Z","timestamp":1786118477743,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004375","name":"Tel Aviv University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004375","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Paternity rates among testicular cancer survivors are reduced. The patient journey, from fertility preservation at diagnosis to attempted paternity or use of assisted reproductive technologies (ART), contains two key gaps in the literature. While baseline semen impairment is well recognized, the relationship between disease stage, tumor pathology, and semen quality remains inconsistent. In addition, prior studies have largely excluded sex-cord stromal tumors, lacked healthy comparators, and rarely performed pathology-specific analyses within the same clinical stage. Reported paternity rates vary widely (6\u201321%), yet real-world data on ART utilization and live-birth outcomes remain limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study (2017\u20132023) at a single tertiary academic referral center within a healthcare system that provided full coverage for sperm cryopreservation for 5\u00a0years and ART for up to 2 live births. Primary outcomes included baseline semen parameters by tumor histology and clinical stage, pathology-specific comparisons within each stage, and post-treatment utilization of cryopreserved sperm. Secondary outcomes were ART pregnancy and live-birth rates. The semen parameters were compared with those of healthy sperm donor candidates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The cohort included 126 men (mean age 36.6\u2009\u00b1\u200910.9\u00a0years; 83 seminoma, 35 non-seminoma, 8 sex-cord stromal tumors). Compared with 100 healthy donor candidates, testicular cancer patients demonstrated significantly impaired baseline semen quality across all parameters except volume (all p\u2009\u2264\u20090.01). Post-thaw semen quality was further reduced, with lower motility rates (17.5% vs 44.1%) and total motile counts (1.1 vs 7.8 million), highlighting greater motility and total motile count loss following cryopreservation. Sex-cord stromal tumors exhibited the poorest semen parameters. Semen quality did not differ by stage overall; pathology-specific differences were observed only in stage II disease, favoring non-seminoma tumors (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009\u2264\u20090.05). Overall, 69% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200991) elected sperm cryopreservation. Among those, the median number of vials initially frozen was 15 (IQR 10\u201318), with a mean of 11.6\u2009\u00b1\u20094.3 vials per patient (range 1\u201318). During a median follow-up of 5.3\u00a0years (IQR: 3.9\u20136.8), only 8% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20097) used their vials for ART, undergoing a median (IQR) of 2.5 (1\u20134) cycles per couple (15 cycles recorded among 6 of 7 couples; cycle count missing for one couple), resulting in 12 pregnancies and an overall live-birth rate of 67%: IUI: 2\/2, 100%, IVF: 6\/10, 60%.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Testicular cancer significantly impairs semen quality, with important variation by tumor pathology rather than stage. These findings underscore the need for accurate counseling: fertility preservation often enables future use primarily through IVF and supports banking multiple vials to mitigate freeze\u2013thaw losses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11255-026-05326-7","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:00:41Z","timestamp":1786032041000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Semen quality at diagnosis, cryopreservation utilization, and reproductive outcomes in testicular cancer: a longitudinal cohort study"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5668-1330","authenticated-orcid":false,"given":"Karin","family":"Lifshitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimi","family":"Barda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaul","family":"Gefel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avishai","family":"Delougi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofer","family":"Yossepowitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra Edith","family":"Kleiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snir","family":"Dekalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noga Fuchs","family":"Weizman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"5326_CR1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012390","author":"JS Park","year":"2018","unstructured":"Park JS, Kim J, Elghiaty A, Ham WS (2018) Recent global trends in testicular cancer incidence and mortality. Medicine (Baltimore). https:\/\/doi.org\/10.1097\/MD.0000000000012390","journal-title":"Medicine (Baltimore)"},{"key":"5326_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/and.51","author":"L Caponecchia","year":"2015","unstructured":"Caponecchia L, Cimino G, Sacchetto R et al (2015) Do malignant diseases affect semen quality? Sperm parameters of men with cancers. Published online. https:\/\/doi.org\/10.1111\/and.51","journal-title":"Published online"},{"issue":"7","key":"5326_CR3","doi-asserted-by":"publisher","first-page":"539","DOI":"10.18502\/ijrm.v13i7.7371","volume":"18","author":"B Ghasemi","year":"2020","unstructured":"Ghasemi B, Mehrjardi AM, Jones C, Ghasemi N (2020) Semen analysis of subfertility caused by testicular carcinoma. Int J Reprod Biomed 18(7):539\u2013550. https:\/\/doi.org\/10.18502\/ijrm.v13i7.7371","journal-title":"Int J Reprod Biomed"},{"issue":"2","key":"5326_CR4","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/J.JURO.2008.10.023","volume":"181","author":"IVDH Williams","year":"2020","unstructured":"Williams IVDH, Karpman E, Sander JC, Spiess PE, Pisters LL, Lipshultz LI (2020) Pretreatment semen parameters in men with cancer. J Urol 181(2):736\u2013740. https:\/\/doi.org\/10.1016\/J.JURO.2008.10.023","journal-title":"J Urol"},{"key":"5326_CR5","unstructured":"Diagnosis and Treatment of Early Stage Testicular Cancer: AUA Guideline (2019) - American Urological Association. Accessed June 8, 2023. https:\/\/www.auanet.org\/guidelines-and-quality\/guidelines\/testicular-cancer-guideline"},{"key":"5326_CR6","unstructured":"Testicular Cancer EAU Guidelines on. Published online 2023."},{"issue":"6","key":"5326_CR7","doi-asserted-by":"publisher","first-page":"672","DOI":"10.6004\/JNCCN.2009.0047","volume":"7","author":"RJ Motzer","year":"2009","unstructured":"Motzer RJ, Agarwal N, Beard C et al (2009) NCCN clinical practice guidelines in oncology: testicular cancer. J Natl Compr Canc Netw 7(6):672\u2013693. https:\/\/doi.org\/10.6004\/JNCCN.2009.0047","journal-title":"J Natl Compr Canc Netw"},{"issue":"8","key":"5326_CR8","doi-asserted-by":"publisher","first-page":"851","DOI":"10.6004\/JNCCN.2023.0040","volume":"21","author":"S Bhatia","year":"2024","unstructured":"Bhatia S, Pappo AS, Acquazzino M et al (2024) Adolescent and young adult (AYA) oncology, version 2.2024, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 21(8):851\u2013880. https:\/\/doi.org\/10.6004\/JNCCN.2023.0040","journal-title":"J Natl Compr Canc Netw"},{"issue":"12","key":"5326_CR9","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1200\/JCO-24-02782;WGROUP:STRING:PUBLICATION","volume":"43","author":"HI Su","year":"2025","unstructured":"Su HI, Lacchetti C, Letourneau J et al (2025) Fertility preservation in people with cancer: ASCO guideline update. J Clin Oncol 43(12):1488\u20131515. https:\/\/doi.org\/10.1200\/JCO-24-02782;WGROUP:STRING:PUBLICATION","journal-title":"J Clin Oncol"},{"issue":"3","key":"5326_CR10","doi-asserted-by":"publisher","first-page":"151.e11","DOI":"10.1016\/J.UROLONC.2022.11.004","volume":"41","author":"RR Badia","year":"2023","unstructured":"Badia RR, Patel A, Chertack N, Howard JM, Bagrodia A, Bakare T (2023) Impact of testicular cancer stage on semen parameters in patients before orchiectomy. Urol Oncol Semin Orig Investig 41(3):151.e11-151.e15. https:\/\/doi.org\/10.1016\/J.UROLONC.2022.11.004","journal-title":"Urol Oncol Semin Orig Investig"},{"issue":"3","key":"5326_CR11","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/S10147-019-01534-7","volume":"25","author":"MA U\u00e7ar","year":"2020","unstructured":"U\u00e7ar MA, Arikan F, Co\u015fkun H\u015e, Kondak Y, Tatl\u0131 AM, G\u00f6ksu SS (2020) Fertility in testicular cancer patients: a single-centre study in Turkey. Int J Clin Oncol 25(3):495\u2013500. https:\/\/doi.org\/10.1007\/S10147-019-01534-7","journal-title":"Int J Clin Oncol"},{"issue":"6","key":"5326_CR12","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1691\/ph.2014.3912R","volume":"69","author":"Z Moln\u00e1r","year":"2014","unstructured":"Moln\u00e1r Z, Berta E, Beny\u00f3 M et al (2014) Fertility of testicular cancer patients after anticancer treatment - experience of 11 years. Pharmazie 69(6):437\u2013441. https:\/\/doi.org\/10.1691\/ph.2014.3912R","journal-title":"Pharmazie"},{"issue":"1","key":"5326_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ejogrb.2013.06.021","volume":"170","author":"MD Johnson","year":"2013","unstructured":"Johnson MD, Cooper AR, Jungheim ES, Lanzendorf SE, Odem RR, Ratts VS (2013) Sperm banking for fertility preservation: a 20-year experience. Eur J Obstet Gynecol Reprod Biol 170(1):177\u2013182. https:\/\/doi.org\/10.1016\/j.ejogrb.2013.06.021","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"Suppl 1","key":"5326_CR14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.21037\/TAU.2019.08.08","volume":"9","author":"NV Parekh","year":"2020","unstructured":"Parekh NV, Lundy SD, Vij SC (2020) Fertility considerations in men with testicular cancer. Transl Androl Urol 9(Suppl 1):14\u201323. https:\/\/doi.org\/10.21037\/TAU.2019.08.08","journal-title":"Transl Androl Urol"},{"key":"5326_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji339","author":"M Brydy","year":"2005","unstructured":"Brydy M, Fossa SD, Klepp O et al (2005) Paternity following treatment for testicular cancer. J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/dji339","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"5326_CR16","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1001\/JAMA.2024.27122","volume":"333","author":"N Singla","year":"2025","unstructured":"Singla N, Bagrodia A, Baraban E, Fankhauser CD, Ged YMA (2025) Testicular germ cell tumors: a review. JAMA 333(9):793\u2013803. https:\/\/doi.org\/10.1001\/JAMA.2024.27122","journal-title":"JAMA"},{"issue":"1","key":"5326_CR17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/JNCI\/DJAB130","volume":"114","author":"M Bandak","year":"2022","unstructured":"Bandak M, Jensen A, Dehlendorff C et al (2022) Paternity after treatment for testicular germ cell cancer: a Danish nationwide population-based cohort study. J Natl Cancer Inst 114(1):149\u2013155. https:\/\/doi.org\/10.1093\/JNCI\/DJAB130","journal-title":"J Natl Cancer Inst"},{"key":"5326_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/HUMREP\/DEAD026","author":"M Kitlinski","year":"2023","unstructured":"Kitlinski M, Giwercman A, Elenkov A (2023) Paternity through use of assisted reproduction technology in male adult and childhood cancer survivors: a nationwide register study. Hum Reprod. https:\/\/doi.org\/10.1093\/HUMREP\/DEAD026","journal-title":"Hum Reprod"},{"issue":"1","key":"5326_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.5935\/1518-0557.20170009","volume":"21","author":"A MacKenna","year":"2017","unstructured":"MacKenna A, Crosby J, Huidobro C, Correa E, Duque G (2017) Semen quality before cryopreservation and after thawing in 543 patients with testicular cancer. JBRA Assist Reprod 21(1):31\u201334. https:\/\/doi.org\/10.5935\/1518-0557.20170009","journal-title":"JBRA Assist Reprod"},{"issue":"3","key":"5326_CR20","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S0090-4295(99)80224-6","volume":"46","author":"A Agarwal","year":"1995","unstructured":"Agarwal A, Tolentino MV, Sidhu MDRS et al (1995) Effect of cryopreservation on semen quality in patients with testicular cancer. Urology 46(3):382\u2013389. https:\/\/doi.org\/10.1016\/S0090-4295(99)80224-6","journal-title":"Urology"},{"issue":"5","key":"5326_CR21","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/S0090-4295(99)00267-8","volume":"54","author":"J Hallak","year":"1999","unstructured":"Hallak J, Kolettis PN, Sekhon VS, Thomas AJ, Agarwal A (1999) Sperm cryopreservation in patients with testicular cancer. Urology 54(5):894\u2013899. https:\/\/doi.org\/10.1016\/S0090-4295(99)00267-8","journal-title":"Urology"},{"issue":"2","key":"5326_CR22","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/S0015-0282(97)81919-X","volume":"67","author":"OF Padron","year":"1997","unstructured":"Padron OF, Sharma RK, Thomas AJ, Agarwal A (1997) Effects of cancer on spermatozoa quality after cryopreservation: a 12- year experience. Fertil Steril 67(2):326\u2013331. https:\/\/doi.org\/10.1016\/S0015-0282(97)81919-X","journal-title":"Fertil Steril"},{"issue":"3","key":"5326_CR23","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.rbmo.2011.11.015","volume":"24","author":"P Bizet","year":"2012","unstructured":"Bizet P, Saias-Magnan J, Jouve E et al (2012) Sperm cryopreservation before cancer treatment: a 15-year monocentric experience. Reprod Biomed Online 24(3):321\u2013330. https:\/\/doi.org\/10.1016\/j.rbmo.2011.11.015","journal-title":"Reprod Biomed Online"},{"key":"5326_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2012.09.031","author":"JM Hotaling","year":"2013","unstructured":"Hotaling JM, Lopushnyan NA, Davenport M et al (2013) Raw and test-thaw semen parameters after cryopreservation among men with newly diagnosed cancer. Fertil Steril. https:\/\/doi.org\/10.1016\/j.fertnstert.2012.09.031","journal-title":"Fertil Steril"},{"issue":"1","key":"5326_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.rbmo.2016.04.002","volume":"33","author":"S Ferrari","year":"2016","unstructured":"Ferrari S, Paffoni A, Filippi F, Busnelli A, Vegetti W, Somigliana E (2016) Sperm cryopreservation and reproductive outcome in male cancer patients: a systematic review. Reprod Biomed Online 33(1):29\u201338. https:\/\/doi.org\/10.1016\/j.rbmo.2016.04.002","journal-title":"Reprod Biomed Online"},{"key":"5326_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-024-05725-2","author":"V Menzel","year":"2024","unstructured":"Menzel V, Richter E, Helke C et al (2024) Utilization of sperm cryopreservation in patients with testicular cancer. J Cancer Res Clin Oncol. https:\/\/doi.org\/10.1007\/s00432-024-05725-2","journal-title":"J Cancer Res Clin Oncol"},{"key":"5326_CR27","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/575978","author":"J \u017d\u00e1kov\u00e1","year":"2014","unstructured":"\u017d\u00e1kov\u00e1 J, Lousov\u00e1 E, Ventruba P et al (2014) Sperm cryopreservation before testicular cancer treatment and its subsequent utilization for the treatment of infertility. Sci World J. https:\/\/doi.org\/10.1155\/2014\/575978","journal-title":"Sci World J"},{"issue":"8","key":"5326_CR28","doi-asserted-by":"publisher","first-page":"5321","DOI":"10.1007\/s00432-022-04488-y","volume":"149","author":"MJ Fern\u00e1ndez-Gonz\u00e1lez","year":"2023","unstructured":"Fern\u00e1ndez-Gonz\u00e1lez MJ, Radauer-Plank AC, Stelzer C et al (2023) Sperm and testicular tissue cryopreservation and assisted reproductive technology outcomes in male cancer patients: a 15-year experience. J Cancer Res Clin Oncol 149(8):5321\u20135330. https:\/\/doi.org\/10.1007\/s00432-022-04488-y","journal-title":"J Cancer Res Clin Oncol"},{"key":"5326_CR29","unstructured":"McVay GJ, Cooke DJ. WHO laboratory manual for the examination and processing of human semen. Healthc Financ Manage. 2006;60(10):100\u2013102, 104, 106 passim. Accessed February 11, 2026. https:\/\/www.who.int\/publications\/i\/item\/9789240030787"},{"key":"5326_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/jncimonographs\/lgi005","volume":"34","author":"A Agarwal","year":"2005","unstructured":"Agarwal A, Allamaneni SSR (2005) Disruption of spermatogenesis by the cancer disease process. J Natl Cancer Inst Monogr 34:9\u201312. https:\/\/doi.org\/10.1093\/jncimonographs\/lgi005","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"3","key":"5326_CR31","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/S0022-5347(17)36732-0","volume":"148","author":"GT Ho","year":"1992","unstructured":"Ho GT, Gardner H, DeWolf WC, Loughlin KR, Morgentaler A (1992) Influence of testicular carcinoma on ipsilateral spermatogenesis. J Urol 148(3):821\u2013825. https:\/\/doi.org\/10.1016\/S0022-5347(17)36732-0","journal-title":"J Urol"},{"issue":"6","key":"5326_CR32","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.2164\/JANDROL.112.016592","volume":"33","author":"N Rives","year":"2012","unstructured":"Rives N, Perdrix A, Hennebicq S et al (2012) The semen quality of 1158 men with testicular cancer at the time of cryopreservation: results of the French National CECOS Network. J Androl 33(6):1394\u20131401. https:\/\/doi.org\/10.2164\/JANDROL.112.016592","journal-title":"J Androl"},{"key":"5326_CR33","doi-asserted-by":"publisher","DOI":"10.4081\/AIUA.2024.12238","author":"G Mendes","year":"2024","unstructured":"Mendes G, Teixeira B, Madanelo M et al (2024) Semen parameters in testicular tumor patients before orchiectomy: what is the impact of testicular tumor stage and histology. Arch Ital Urol Androl. https:\/\/doi.org\/10.4081\/AIUA.2024.12238","journal-title":"Arch Ital Urol Androl"},{"key":"5326_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00122","author":"M Ghezzi","year":"2016","unstructured":"Ghezzi M, Berretta M, Bottacin A et al (2016) Impact of bep or carboplatin chemotherapy on testicular function and sperm nucleus of subjects with testicular germ cell tumor. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2016.00122","journal-title":"Front Pharmacol"},{"issue":"10","key":"5326_CR35","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1111\/IJU.14645","volume":"28","author":"S Yamashita","year":"2021","unstructured":"Yamashita S, Kakimoto K, Uemura M et al (2021) Fertility and reproductive technology use in testicular cancer survivors in Japan: a multi-institutional, cross-sectional study. Int J Urol 28(10):1047\u20131052. https:\/\/doi.org\/10.1111\/IJU.14645","journal-title":"Int J Urol"},{"issue":"1","key":"5326_CR36","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.fertnstert.2020.11.016","volume":"115","author":"PN Schlegel","year":"2021","unstructured":"Schlegel PN, Sigman M, Collura B et al (2021) Diagnosis and treatment of infertility in men: AUA\/ASRM guideline part II. Fertil Steril 115(1):62\u201369. https:\/\/doi.org\/10.1016\/j.fertnstert.2020.11.016","journal-title":"Fertil Steril"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05326-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05326-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05326-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:00:53Z","timestamp":1786032053000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-026-05326-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":36,"alternative-id":["5326"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05326-7","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"assertion":[{"value":"20 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there are no competing interests.\n                      Ethical approval and consent of participation.\n                      The study received approval from the internal review board at TLVMC (TLV No. 0319\u201324).","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}